...
首页> 外文期刊>Clinical chemistry and laboratory medicine: CCLM >Development and validation of a 2nd tier test for identification of purine nucleoside phosphorylase deficiency patients during expanded newborn screening by liquid chromatography-tandem mass spectrometry
【24h】

Development and validation of a 2nd tier test for identification of purine nucleoside phosphorylase deficiency patients during expanded newborn screening by liquid chromatography-tandem mass spectrometry

机译:液相色谱-串联质谱扩大新生儿筛查过程中鉴定嘌呤核苷磷酸化酶缺乏症患者的第二层试验的开发和验证

获取原文
获取原文并翻译 | 示例
           

摘要

Background: Purine nucleoside phosphorylase (PNP) deficiency has been recently introduced in the newborn screening program in Tuscany. In order to improve the PNP screening efficiency, we developed a 2nd tier test to quantify PNP primary markers deoxyguanosine (dGuo) and deoxyinosine (dIno).
机译:背景:最近在托斯卡纳的新生儿筛查计划中引入了嘌呤核苷磷酸化酶(PNP)缺乏症。为了提高PNP筛选效率,我们开发了第二层测试来量化PNP主要标志物脱氧鸟苷(dGuo)和脱氧肌苷(dIno)。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号